Correlation Between GlaxoSmithKline PLC and Sonmez Pamuklu

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Sonmez Pamuklu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Sonmez Pamuklu into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Sonmez Pamuklu Sanayii, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Sonmez Pamuklu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Sonmez Pamuklu. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Sonmez Pamuklu.

Diversification Opportunities for GlaxoSmithKline PLC and Sonmez Pamuklu

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between GlaxoSmithKline and Sonmez is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Sonmez Pamuklu Sanayii in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonmez Pamuklu Sanayii and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Sonmez Pamuklu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonmez Pamuklu Sanayii has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Sonmez Pamuklu go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Sonmez Pamuklu

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Sonmez Pamuklu. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.41 times less risky than Sonmez Pamuklu. The stock trades about -0.3 of its potential returns per unit of risk. The Sonmez Pamuklu Sanayii is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  6,065  in Sonmez Pamuklu Sanayii on August 28, 2024 and sell it today you would earn a total of  95.00  from holding Sonmez Pamuklu Sanayii or generate 1.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy90.91%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Sonmez Pamuklu Sanayii

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Sonmez Pamuklu Sanayii 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sonmez Pamuklu Sanayii has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Sonmez Pamuklu is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

GlaxoSmithKline PLC and Sonmez Pamuklu Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Sonmez Pamuklu

The main advantage of trading using opposite GlaxoSmithKline PLC and Sonmez Pamuklu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Sonmez Pamuklu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonmez Pamuklu will offset losses from the drop in Sonmez Pamuklu's long position.
The idea behind GlaxoSmithKline PLC ADR and Sonmez Pamuklu Sanayii pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities